Resona Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Buy
711
+127
+22% +$22.6K ﹤0.01% 744
2026
Q1
$93.3K Hold
584
﹤0.01% 771
2025
Q4
$119K Hold
584
﹤0.01% 772
2025
Q3
$85.8K Buy
584
+87
+18% +$13.8K ﹤0.01% 790
2025
Q2
$74.6K Buy
497
+18
+4% +$2.4K ﹤0.01% 810
2025
Q1
$74.5K Sell
479
-14,848
-97% -$2.49M ﹤0.01% 786
2024
Q4
$2.83M Sell
15,327
-387
-2% -$74.5K 0.02% 554
2024
Q3
$3.1M Buy
15,714
+726
+5% +$151K 0.02% 549
2024
Q2
$3.1M Sell
14,988
-1,813
-11% -$411K 0.02% 539
2024
Q1
$4.55M Buy
+16,801
New +$4.01M 0.03% 495

Other funds holding CRL

Resona Asset Management's CRL Position: Q2 2026 in Review

Resona Asset Management increased its Charles River Laboratories (CRL) stake by 22% in Q2 2026, buying an estimated $22.6K and bringing the position to 711 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #744.

Resona Asset Management first reported a position in CRL in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.55M in Q1 2024. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Resona Asset Management held 711 shares of Charles River Laboratories worth $160K as of Q2 2026.
  • Resona Asset Management bought 127 Charles River Laboratories shares in Q2 2026, an estimated $22.6K.
  • Charles River Laboratories made up ﹤0.01% of Resona Asset Management's portfolio in Q2 2026, its #744 holding.
  • Resona Asset Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's Charles River Laboratories position peaked at $4.55M in Q1 2024.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.